FDA looks to crack down on illegal opioid marketers in the US with help of social networks

The US’s Food and Drug Administration latest crackdown is targeting pharmacies selling illegal opioids online. The agency has issued warning letters this week to nine online pharmacies that run 53 websites selling drugs with suspect monikers like “Roxycodone” and “Tramadol Generic.” The majority of the websites were shut down a day later, aside from OneStopPharma.org—was

Continue Reading

Could Facebook’s data scraping affect healthcare and pharma?

Another internet data scandal, Facebook and Cambridge Analytica, has consumers concerned about the safety of their personal information. Will people become more nervous about sharing their healthcare data in its wake? Probably not, stated several industry experts interviewed by FiercePharma, although pharma companies should still be aware of the controversy. Cambridge Analytica’s mishandling of data

Continue Reading

Novo Nordisk discusses lessons from a diabetes education campaign at the ePharma Summit

To address the lack of online information about diabetes, Novo Nordisk turned to YouTube star Michael Stevens, who runs the Vsauce channel, and collated a mix of marketing strategies that includes influencers, original content, and SEO. Jeremy Shepler, head of U.S. commercialization for Novo Nordisk’s diabetes drug Ozempic, talked about the lessons learned from the

Continue Reading

Youtube and Google begin to take measures to earn back trust from brands and agencies

Google has taken measured steps to earn back trust from advertisers and agencies, after a series of controversies around brand safety, including adverts being displayed on extremist content. The latest announcement pledges to impose stricter rules for video creators who wish to seek remuneration through the YouTube Partner Program, including achieving at least 1,000 subscribers

Continue Reading

Dedicated US Social Network for Heart Failure Patients Launched by Novartis

When pharma giant Novartis first started marketing Entresto, a heart failure drug, it found itself facing criticism from cardiologists and consumers who found the direct-to-consumer ads too negative. In light of the criticism, Novartis has now taken a different approach to promoting the heart failure drug. In partnership with the American Heart Association and actress/singer

Continue Reading